Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents

Research output: Contribution to journalLetterResearchpeer-review

Documents

  • Fulltext

    Final published version, 259 KB, PDF document

In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.

Original languageEnglish
JournalPediatric Infectious Disease Journal
Volume41
Issue number1
Pages (from-to)E25-E28
Number of pages4
ISSN0891-3668
DOIs
Publication statusPublished - Jan 2022

    Research areas

  • mRNA COVID-19 vaccine, myopericarditis, adolescents Accepted for publication October 10, 2021

ID: 315536037